DePuy Synthes Down 7.5%, Bracing For More Extreme Declines

DePuy Synthes' logo

DePuy Synthes reported 1Q20 orthopedic revenue of USD $2,038 million, -7.5% vs. 1Q19. Johnson & Johnson, the parent company of DePuy Synthes, lowered its 2020 full-year guidance to account for the negative impact of COVID-19. Guidance for total reported sales was lowered from a range of $85.4 billion to $86.2 billion (+4% to +5%) in...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us